Lionel B. Ivashkiv

Prof. Dr. Lionel B. Ivashkiv

Department of Medicine at Hospital for Special Surgery and Division of Rheumatology at HSS, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2013 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
LILionel B. Ivashkiv
Lionel B. Ivashkiv
LDLaura T. Donlin
Laura T. Donlin

19 June 2018 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
LILionel B. Ivashkiv
Lionel B. Ivashkiv

10 December 2015 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
George D. KallioliasGeorge D. Kalliolias
George D. Kalliolias
LILionel B. Ivashkiv
Lionel B. Ivashkiv


23 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
FMFumitaka Mizoguchi
Fumitaka Mizoguchi
KSKamil Slowikowski
Kamil Slowikowski
KWKevin Wei
Kevin Wei
JMJennifer L. Marshall
Jennifer L. Marshall
DRDeepak A. Rao
Deepak A. Rao
MBMichael B. Brenner
Michael B. Brenner
Fibroblasts regulate tissue homeostasis, coordinate inflammatory responses, and mediate tissue damage. In rheumatoid arthritis (RA), synovial fibroblasts maintain chronic inflammation which leads to joint destruction. Little is known about fibroblast heterogeneity or if aberrations in fibroblast subsets relate to pathology. Here, we show functional and transcriptional differences between fibroblast subsets from human synovial tissues using bulk transcriptomics of targeted subpopulations and single-cell transcriptomics. We identify seven fibroblast subsets with distinct surface protein phenotypes, and collapse them into three subsets by integrating transcriptomic data. One fibroblast subset, characterized by the expression of proteins podoplanin, THY1 membrane glycoprotein and cadherin-11, but lacking CD34, is threefold expanded in patients with RA relative to patients with osteoarthritis. These fibroblasts localize to the perivascular zone in inflamed synovium, secrete proinflammatory cytokines, are proliferative, and have an in vitro phenotype characteristic of invasive cells. Our strategy may be used as a template to identify pathogenic stromal cellular subsets in other complex diseases.

19 November 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
FBFranck J. Barrat
Franck J. Barrat
MCMary K. Crow
Mary K. Crow
LILionel B. Ivashkiv
Lionel B. Ivashkiv